Arianna R. Houriani

Arianna Houriani practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Arianna Houriani's NPI, 1255828562, was assigned on April 23, 2018. Arianna Houriani holds California license A173425.

Arianna Houriani's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Arianna Houriani's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Arianna Houriani is also affiliated with Cedars-Sinai Marina Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Arianna Houriani to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arianna Houriani practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Arianna Houriani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Arianna Houriani is licensed in California.

CMS data shows 755 Medicare services from Arianna Houriani across 4 procedure codes in 2024, for 248 Medicare patients. Medicare paid $72,271 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Arianna Houriani in 2024. The largest group is 75 to 84, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Arianna Houriani's median patient age at 71, with 51% women.

In 2024, Arianna Houriani wrote 172 Medicare Part D claims for 78 patients. 77% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $68 in total drug cost. In 2022, CMS named 39 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Arianna Houriani for performance year 2024, reported as part of a group. Arianna Houriani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Arianna Houriani from 6 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $226.